FDA awards Neuralert Technologies Breakthrough Device designation
The Center for Devices and Radiological Health (CDRH) of the FDA has granted the Neuralert Monitor designation as a Breakthrough Device.
Philadelphia-area VC funding smashes annual record just halfway through 2021
Philadelphia-area firms raised $3.1 billion in venture capital funding during the first half of 2021, already smashing an annual record set two years ago.
Introducing the 2021 Pennovation Accelerator Eco-Impact Cohort
The 2021 Pennovation Accelerator officially launched Monday, July 12th for the program's fourth summer!
Regional collaborations emerge to address the biomanufacturing workforce crisis
In Philadelphia alone, cell and gene therapy and gene editing companies are preparing to add more than 1,100 new employees per year for the next decade, a net gain of more than 6,000 new workers.
PACT Recognizes Technology, Healthcare and Life Sciences Innovation and Leaders in the Philadelphia Region at the 2021 Enterprise Awards
Philadelphia Alliance for Capital and Technologies culminated two days celebrating the region’s technology, healthcare and life sciences innovators and leaders at the 2021 Enterprise Awards.
NextUp: The Philly biotech company developing an in vivo approach to CAR T-Cell therapy
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
Webinar Recording: Tips from Early Stage Investors
Gain insight from Venture Capitalists who focus on investing in early stage University startups. Recorded on May 19, 2021.